The program cost and cost-effectiveness of screening men for Chlamydia to prevent pelvic inflammatory disease in women

Sex Transm Dis. 2008 Nov;35(11 Suppl):S66-75. doi: 10.1097/OLQ.0b013e31818b64ac.


Background: Because men transmit Chlamydia trachomatis to women, screening men to prevent pelvic inflammatory disease in women may be a viable strategy. However, the cost-effectiveness of this approach requires careful assessment.

Methods: Data from a demonstration project and longitudinal study that examined screening men for chlamydia were applied to a compartment-based transmission model to estimate the cost-effectiveness of screening men for chlamydia compared with alternative interventions, including expanded screening of women and combining disease investigation specialist-provided partner notification with screening. Cases of pelvic inflammatory disease and quality-adjusted life years lost were the primary outcome measures. A male screening program that screened 1% of men in the population annually was modeled.

Results: A program targeting high-risk men for screening (those with a larger number of partners in the previous year than the general population and a higher chlamydia prevalence) was cost saving compared with using equivalent program dollars to expand screening of lower-risk women. Combining partner notification with male screening was more effective than screening men alone. In sensitivity analyses, the male program was not always cost saving but averaged $10,520 per quality-adjusted life year saved over expanded screening of women.

Conclusions: Screening men can be a cost-effective alternative to screening women, but the men screened must have a relatively high prevalence compared with the women to whom screening would be expanded (under baseline assumptions, the prevalence in screened men was 86% higher than that of screened women). These modeling results suggest that programs targeting venues that have access to high-risk men can be effective tools in chlamydia prevention.

MeSH terms

  • Adolescent
  • Adult
  • Chlamydia Infections* / diagnosis
  • Chlamydia Infections* / economics
  • Chlamydia Infections* / microbiology
  • Chlamydia Infections* / transmission
  • Chlamydia trachomatis / isolation & purification
  • Contact Tracing / economics
  • Cost-Benefit Analysis / economics
  • Female
  • Humans
  • Male
  • Mass Screening / economics*
  • Pelvic Inflammatory Disease / epidemiology
  • Pelvic Inflammatory Disease / microbiology
  • Pelvic Inflammatory Disease / prevention & control*
  • Prevalence
  • Program Evaluation*
  • Quality-Adjusted Life Years
  • Sexual Partners
  • United States
  • Urban Health
  • Young Adult